Laryngopharyn geal reflux (LPR) is an extraesoph ageal variant of gastroesophageal reflux disease (GERD) that affects th e larynx and pharynx. In recent years, many otolaryngologists have acknowledged the existence and po tential importance of LPR in patients with otolaryngologic complaints, ' altho ugh th e associa tio n between acid reflux and laryn geal abnormalities has been recogni zed for more th an 4 decades." ? As otolaryngo logists have been m ore diligent abo ut looking for signs of LPR-such as pos terior laryngeal edema an d erythema, obliterati on of th e laryngeal ventricles, and int eraryten oid hyp ertrophy-treatme nt for LPR based on th ese findings has become increasingly common .
Because of a paucity of convin cing evidence regar ding tech niqu es for establishing definitive diagnosis an d causation in individual patients, and because of a plethora of imperfect stud ies that have produced confl icting conclusions, LPR diagnosis and management remain controversial. Nevertheless, most recent evidence suggests that LPR represents a complex spectrum of abnormalities. It is essential for oto laryngologists an d gastroentero logists (as well as other health care pr oviders) to un derstand th e latest concepts in basic science and elinical care of patient s wit h LPR.
Symp to ms an d signs of LPR have been report ed in 4 to 10% of all patients seen by oto lary ngo logists,"!' but it is likely tha t th ese estimates are low. Amo ng patients who present with voice disorders, th e estimated prevalence is much hig her. In 1989, Wiener et al repo rted that 78% of32 patient s with voice complaints had LPR documented by pH probe." Koufman found LPR in 78% of pat ients with hoarseness, and in ro ughly 50% of all patients who presented with voice complaint s." Many ot her publications have addressed the pathogenesis of voice disorders and oto laryngologic m ani festation s of LPR, as well as its prevale nce.P '" :" Yet, definit ive epi demiologic studies to confirm the prevalenc e and oto lary ngologic conse que nces of LPR are still lackin g. Consequently,wh ile m any physician s believe the con dition is still underdiagn osed, many also suspect overdiagnosis and m isdiagnosis in many pa tien ts.
LPR is believed to damage the larynx either directly or secondarily. Direct injury is due to the contact of acid and pepsin with laryngeal mucosa, resulting in m ucosa l injury. 4,5.15-1SAlternatively, laryngeal irritation and injury may be prod uced without direct acid contact with the larynx whe n irritation of the dista l esop hagus by acid triggers a vagus nerve response that produ ces chron ic cough and throat cleari ng capable of traumatizing laryngeal mucosa." :" Bile reflux m ay also be a cause of laryn geal m ucosal inflam mation."
Other, more soph isticated, factors m ay be important, as well. For example, Eckley et al reported that decreased salivary epidermal growth factor appears to be associated with LPR 23 ,24; an d Altman et al discovered a proton pump in laryngea l serous cells and ducts, raising additional intriguing questions about the pathophysiology of LPR. 25 It has long been asserted that nonacid reflux also can trigger cough and throat clearing and cause mucosal irritation that is tro ublesome to some voice patients, and recent experience with im pedance mo ni toring has confirmed th e association between nonacid reflux and such symptoms .
LPR has been assoc iated with numerou s laryn geal conditions, incl uding muswww.entjourna l.com · 549 EDITORIAL cle tension dysphonia, Reinke's edema, globus pharyngeus, laryngeal hyperirritability, laryngospasm, delayed wound healing, posterior laryngitis, diffuse laryngitis, laryngeal pyogenic granuloma, glottic and subglottic stenosis, cricoarytenoid joint ankylosis, carcinoma, and other conditions.':" LPR has also been associated with sudden infant death syndrome,13,26-34 probably mediated through the laryngeal chemoreflex.":" Traditionally, otolaryngologists have managed patients with LPRby therapeutic trial. If definite improvement in symptoms and signs is noted after treatment with a proton pump inhibitor (PPI), physicians consider the diagnosis confirmed. For patients who show no response to reflux therapy, some otolaryngologists assume reflux has been ruled out and discontinue the PPI, substituting treatment for allergy or some other condition. In the absence of studies, this approach is particularly problematic, since many patients continue to produce at least some acid despite proton pump inhibitors twice daily, and it has been recognized for many years that some patients with reflux do not respond to proton pump inhibitors and continue to produce normal amounts of acid despite treatment. " Other otolaryngologists assume that if the patient has failed a therapeutic trial, the LPR is severe and requires even higher doses of PPI therapy, and the addition of other reflux or promotility medications, which often are prescribed empirically (without subjective test for reflux).
At present, our field is in need of definitive, prospective, evidence-based studies. However, while we are awaiting data from such studies, we might benefit from another consensus conference regarding appropriate clinical management with the technology available to us currently. The last such consensus conference statement was pub lished in 1996. 43 Many critical questions need to be addressed to guide clinical care. Among others; they include the following: 1. What constitutes normal acid exposure in the larynx?
The definition of "normal" pH -monitor results rema ins controversial, and there are commonly differences in opinion between laryngologists and gastroenterologists on this important topic. Most of the support for laryngologic opinion is anecdotal, but such clinical judgments should be studied, not dismissed. Many laryngologists (this author among them) believe that in some patients, any laryngeal acid exposure can cause signs and symptoms, even occasional laryngeal 550· www.entjourn al.com acid contact that may on ly occur once every day or two (perhaps less). This intuitively seems plausible . If one placed a single drop of gastric juice in an individ ual's eye every day or two, that eye would probably remain erythematous and more prone to injury than the normal eye if the eye were traumatized by a foreign body, for example. There is no evidence that laryngeal mucosa is any more equipped to tolerate acid contact than the eye.
While this hypothesis is probably true for some patients, it is important for physicians to recognize biologic variab ility. Just as some patients smoke 3 packs a day for 60 years without developing cancer and others develop cancer after using 1 pack a day for 10 years, it is likely that laryngeal response to acid contact varies among individuals. Th is issue requires study, and it also requires consideration when interpreting results of LPR clinical trials, especially when sample size is small.
Despite the paucity of solid evidence, laryngologists have reached many of their opinions about LPR through clinical experience and meticulous patient observation. Unless/until beliefs grounded in the art of medicine are contradicted by evidence-based data, it is reasonab le to take into account clinical "wisdom" when considering protocols for diagnosis and treatment, but they should be tested and augmented by data whenever possible. For example, the author has a growing number of patients who have had persistent symptoms and signs of reflux while using proton pump inhib itors , and whose 24-hour pH impedance monitors have shown continued acid production reaching the proximal sensor. Some of these patients improve with increased proton pump inhibitor therapy; others have continued to have symptoms and signs on four proton pump inhibitors a day and have responded to fundoplication. Interestingly, we also have had some successful fundoplication results in patients who remained symptomatic (positive symptom correlation) from nonacid reflux alone .
Many gastroenterologists remain uncomfortable with our interpretation of these findings, and especially with the trend toward surgery. In general, if a gastroenterologist reads a 24-hour pH impedance study performed on medications, and the study shows four or five episodes of acid reflux at the proximal sensor, he/she will interpret the study as showing "normal acid exposure."
The problem is that the normative data for pH studies were established in patients who had not been me- ticulously screened for extraesophageal reflux disease in general, or for LPR in particular. So many of the norms developed for patients with heartburn, and using absence of heartburn as the primary control criteria, may not be ideal for LPR patients. Close, collaborative studies involving laryngologists, gastroenterologists, and comprehensive, individualized patient evaluation clearly are needed in order to determine the range of effects of acid exposure of various levels, and optimal management.
How should we diagnose LPR, and what constitutes an appropriate evaluation protocol?
Is a successful therapeutic tri al of medication alone adequate? If it is adequate to establish a diagnosis of LPR (particularly if symptoms and signs return when the medicines are stopped), is control of acidity sufficient management for LPR? The gastroenterologists established criteria for esophageal screening based primarily on age and duration of heartburn. The criteria were selected to identify people at risk for Barrett's esophagus and esophageal cancer. However, many LPR patients are young (well under 40) and have no heartburn; but they may have a 3D-year history of reflux beginning at birth. These patients may constitute an "at risk" population that falls outside the current guidelines for screening. Should they all undergo transnasal esophago scopy, esophagogastroduodenoscopy, or some other physical examination? This author suspects that the standard of care will trend in that direction.
3. How should we manage patients who have persistent signs and symptoms (including those who have improvement but not resolution) following treatment with PPls?
In the author's experience, 24-hour pH impedance studies with symptom indices have proven invaluable and offer striking advantages over empirical management alone. Some patients require more than 2 PPIs a day to accomplish complete acid suppression and improvement in symptoms and signs. Others have complete acid control, but they have persistent symptoms caused by nonacid reflux as confirmed by symptom index. Others appear to have symptoms and signs that are not causally related to reflux, and other causes must be sought. However, despite complete acid control, if they had documented reflux off medications, should they undergo esophagoscopy even if the documented reflux is not responsible for their laryngeal comp laints? 552· www.entjourn al.com LPR represents a complex spectrum of pathophysiology, diagnostic challenge, and therapeutic controversy. Patient management can be optimized only through excellently designed studies with rigorous inclusion criteria, involving close collaboration among laryngologists, gastroenterologists, research scientists, and reflux surgeons. Considering the rapidly growing body of knowledge regarding reflux disease, the potentially serious consequences of undertreated reflux, the importance of other entities that may be missed when they are misdiagnosed as reflux, and the national and international interdisciplinary collegiality that exists currently, there is every reason to believe it is possible to establish interinstitutional, unbiased collaboration that should provide answers to these important clinical questions in the near future . This in turn shou ld lead to consensus regarding rat ional diagno sis of and treatment for laryngopharyngeal reflux. 
